The Sei Foundation is embarking on an ambitious venture to acquire the bankrupt genomics company 23andMe. This initiative aims to bring the genetic data of 15 million users onto a blockchain platform. The goal is to enhance privacy, ownership, and control over genomic information, which the Sei Foundation considers its boldest move in Decentralized Science. Will this acquisition revolutionize the way genetic data is managed, or is it fraught with challenges?